Target intelligence / Profile preview

Thymosin beta 10 pseudogene

Molecular classification: Other (Pseudogene)

Overview

Thymosin beta 10 pseudogene is classified as a pseudogene of the functional gene *TMSB10* (thymosin beta 10). Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode a functional protein product. There is currently no evidence indicating this pseudogene is a therapeutic target, is involved in biological pathways, or has any established role in disease, biomarker utility, or drug interactions. The *TMSB10* protein-coding gene (distinct from the pseudogene) is involved in actin dynamics and cancer biology, but the pseudogene itself does not fulfill the criteria of a biomedical target[2].

Other names: TMSB10PTMSB10P2thymosin beta 10 pseudogene 2

Beyond the preview

Go deeper on Thymosin beta 10 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thymosin beta 10 pseudogene.

Explore the full profile